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Abstract 
Background: Most recently, a novel myokine, named irisin, was identified in human that expressed by skeletal mus-
cle after exercise. Irisin increases energy expenditure by turning white adipose tissue into brown adipose tissue. Thus 
improves carbohydrate homeostasis in humans. Irisin is considered as a potential biomarker for obesity and metabolic 
syndrome. In recent years, numerous studies have been conducted about irisin with adults, although number of stud-
ies with newborns is limited.
Objective: To evaluate cord blood irisin level with small gestational age (SGA) and appropriate gestational age (AGA) 
in term newborns.
Methods: A cross-sectional study of 34 AGA and 34 SGA term newborns who were born in (1–30) December 2015 in 
Fatih University Hospital. Estimated fetal weight were calculated using the Hadlock formula by gynecologists to preg-
nant women in second trimester. All the babies were classified at birth as SGA or AGA. SGA was defined according to 
the Lubchenco scale for gender and gestational age. We collected umbilical cord blood at the time of delivery. Cord 
blood irisin levels were measured using commercial enzyme-linked immunosorbent assays in our hospital laboratory.
Results: Cord blood irisin levels were significantly lower in SGA group [median 30 (25 ± 8) ng/ml] than in AGA group 
[median 40 (39 ± 13) ng/ml, p < 0.001]. No statistically significant differences were observed among the groups in 
terms of the demographic features (gender, mode of delivery, gestational weeks, 1–5 min Apgar score) (p > 0.05). 
Mothers with gestational diabetes, hypertension, asthma, chronic disease, use of drug or a history of smoking expo-
sure were excluded from the study. When the study data were evaluated, Yates Continuity Correction and Fisher’s 
exact tests were used in descriptive statistical methods and for comparison of qualitative data.
Conclusion: Our results support the idea that irisin have a physiologic role in neonates. Low level of irisin is associ-
ated with the impaired carbohydrate metabolism in term infants with SGA. However, further studies with larger series 
are warranted to confirm this.
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Background
In recent years, the interaction between adipose and 
muscle tissues has been increasingly recognized to play 
an important role in body weight regulation and carbo-
hydrate homeostasis. Because the largest organ in the 
body skeletal muscle accounts for the majority of glu-
cose uptake in response to insulin, and is quantitatively 
the most important site of insulin resistance. During 
the past decade, skeletal muscle has also been identified 
as a secretory organ, secreting myostatin, IL-6, IL-15 
and other factors (Pedersen and Febbraio 2012). Most 
recently, a novel myokine, named irisin, was identified in 
mice and human that expressed by skeletal muscle type I 
membrane precursor protein FNDC5 after exercise. It is 
regulated by peroxisome proliferator-activated receptor-y 
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coactivator-1 (PGC1)-a. Irisin increases energy expendi-
ture by turning white adipose tissue (WAT) into brown 
adipose tissue (BAT). Thus improves carbohydrate 
homeostasis in humans (Boström et al. 2012). BAT is the 
second type of adipose tissue, found primarily in mam-
mals and newborn may also affect insülin sensitivity 
and whole-body metabolism via its role in termogenesis 
(Gesta et  al. 2007). Recent studies in mice and humans 
have demonstrated that enhancing brown fat thermogen-
esis may lead to improved glucose tolerance, increased 
sensitivity, lower body weight and decreased fat mass 
(Stanford et al. 2013; Yang et al. 2003). Exogenous admin-
istration of irisin using adenoviral delivery triggered a 
programme of brown-fat-like development in specific 
depots of WAT, and resulted in increased energy expend-
iture, improved glucose tolerance, and a modest but sig-
nificant weight loss (Boström et al. 2012). Changes in the 
total amount of BAT or a reduction in its thermogenic 
capacity could therefore be important precursors of later 
obesity (Rothwell and Stock 1983).
The association between small gestational infant (SGA) 
and impaired insulin sensitivity with the development of 
diseases such as type 2 diabetes, cardiovascular diseases 
or the metabolic syndrome later in life has been dem-
onstrated in several studies (Hofman et  al. 1997; Jaquet 
and Czernichow 2003; Barker 2007). But the underlying 
mechanisms and the relationship between SGA infants 
who have lower muscle and BAT tissue, impaired glucose 
tolerance still remain unclear. There are numerous stud-
ies about irisin in adults. However, the physiologic role of 
irisin in neonates especially in SGA infants remains to be 
studied.
In this study, we aimed to investigate whether there 
was a difference between cord levels of irisin between the 
term infants with SGA and AGA.
Methods
Study population
The present study was prospectively conducted to evalu-
ate cord blood irisin level in SGA and AGA infant. Eth-
ics committee approval was received for this study from 
the ethics committee of Fatih University. The study 
adheres to the Declaration of Helsinki. Written contents 
were received from the families of neonates planned to 
be included in the study. The study included 34 SGA (19 
female and 15 male) and 34 AGA (21 female and 13 male) 
infants who were born in (1–30) December 2015 in Fatih 
University Hospital.
Inclusion criteria
Estimated fetal weight (EFW) were calculated using the 
Hadlock formula by gynecologists to pregnant women 
in second trimester in our hospital, which includes 
abdominal, head circumferences, and femur length meas-
urements (Hadlock et al. 1985).
Exclusion criteria
Newborns with fetal or congenital diseases [TORCH 
infections: Toxoplasmosis, Other (syphilis, varicella-zos-
ter, parvovirus B19), Rubella, Cytomegalovirus (CMV), 
Herpes infections], congenital malformation, neonatal 
sepsis and meconium aspiration that could affect fetal 
growth were excluded. Mothers with gestational diabe-
tes, hypertension, asthma, chronic disease, use of drug 
or a history of smoking exposure were excluded from the 
study.
All the babies were classified at birth as SGA or AGA. 
SGA was defined as birth weight ≤−1.5 SD and AGA 
>−1.5 SD according to the Lubchenco scala for gender 
and gestational age (Lubchenco et al. 1963).
Cord blood collection and measurement of plasma irisin
Umbilical cord blood was collected from the umbilical 
vein attached to the placenta at the time of delivery. They 
were centrifuged and the plasma was divided into 0.5 ml 
aliquots, which were stored in Eppendorf tubes at −80 °C 
until analysis. Cord blood irisin levels  were measured 
using commercial enzyme-linked immunosorbent assays 
(ELISA, Phoenix Pharmaceuticals, Inc., Burlingame, 
CA, USA) in our hospital laboratory. Intra- and inter-
assay variances were <4–6 and <8–10 %, and the range of 
detectable concentration was 0.066–1024 ng/ml.
Statistical analysis
Statistical analyses were performed using the Statisti-
cal Package for Social Sciences-SPSS version 15 software 
(SPSS Inc., Chicago, Illinois). For categorical variables, 
the χ2 test was used. For group comparisons, the Stu-
dent t test was used with a normal distribution, and the 
Mann–Whitney U and Kolmogorov–Smirnov tests with 
abnormal distributions. Kruskal–Wallis test was used for 
continuous variables for comparison between the two dif-
ferent birth weight categories (SGA and AGA). Variance 
analyses and Friedman variance analyses were used for 
repeated measurements. For descriptive statistics, per-
cent, minimum–maximum–median, mean, and stand-
ard deviation were used in accordance with the type and 
distribution of the variable. Normality of irisin was tested 
with Shapiro–Wilk test, and the data were transformed to 
logarithmic scale to obtain normality. A result was con-
sidered statistically significant for values of p < 0.05.
Results
The median birth weight were lower in the SGA 
(2280 ± 221 g) group compared to AGA (3263 ± 329 g). 
There was a strongly significant difference between 
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the two groups in terms of birth weight of the babies 
(p < 0.01). However, no statistically significant differences 
were observed among the groups in terms of the demo-
graphic features (gender, mode of delivery, gestational 
weeks, 1–5 min Apgar score) (p > 0.05).
But cord blood irisin levels were significantly lower in 
SGA group [median 30 (25 ± 8) ng/ml] than in AGA group 
[median 40 (39 ± 13) ng/ml, p < 0.001, Table 1; Fig. 1].
There was not a statistically significant difference 
between the groups in the number of conceptions and 
gestational age (p > 0.05). Mothers with gestational dia-
betes, hypertension, asthma, chronic disease, use of drug 
or a history of smoking exposure were excluded from the 
study. Multivariate linear regression analysis was not car-
ried out, because the pregnants carrying maternal risk 
factors that could affect irisin level.
Discussion
Our prospective study shows that cord blood irisin levels 
are positively correlated with birth weight in term infants 
and the levels are decreased in SGA compared to AGA 
infant. Today number of the studies about serum levels 
of irisin in term infants with SGA and AGA is limited. 
We believe that it would provide contribution to the 
literature.
Because the underlying mechanisms and the rela-
tionship between SGA infants who have lower muscle 
and BAT tissue, impaired glucose tolerance still remain 
unclear. Also irisin is considered as a potential biomarker 
for obesity and metabolic syndrome.
Studies from the literature have usually emphasized 
the excess nutrition during early life include resetting of 
hypothalamic energy sensing and appetite regulation, 
altered adipose tissue insulin sensitivity and impaired 
BAT function (Stettler et al. 2002; Druet et al. 2012; Soto 
et al. 2003; Shalini et al. 2013). Also in animal models it 
has been demonstrated that in utero malnutrition affects 
pancreatic β-cell development leading to impaired β-cell 
function later in life (Garofano et  al. 1997, 1999; Lime-
sand et al. 2005). However this studies have shown that 
excess nutrition is a risk factor for obesity and insulin 
resistance not only in SGA infants but also in AGA neo-
nates. For example; in a large multicentre randomized 
trial of protein supplementation of infant formula milk 
in 1138 infants, those receiving the higher-protein milk 
formula (albeit containing less protein than contempo-
rary commercial formula milks) were of increased body-
weight at 2 years of age (Koletzko et al. 2009).
Today, different physiopathological factors are more 
commonly mentioned in explanation of impaired car-
bohydrate metabolism which is seen more frequently in 
SGA cases and the studies have focused particularly on 
irisin that is seen as a potential biomarker for develop-
ment of obesity and metabolic syndrome. In the most 
Table 1 The demographic characteristics of appropriate for gestational age (AGA) group 1 and small for gestational age 
(SGA) group 2 infants
* p < 0.01
a Student t test
b Mann Whitney U test
c Yates Continuity Correction
d Fisher’s exact test
AGA (n = 34) SGA (n = 34) Total (n = 68) p
Median ± SD Median ± SD
Birth weight (g) 3263 ± 329 2280 ± 221 2771 ± 569 a0.001*
Gestational age (weeks) 38.9 ± 0.2 38.7 ± 0.5 38.8 ± 0.4 a0.108
Apgar score (1th min) 7.79 ± 0.76 7.71 ± 0.74 7.75 ± 0.76 b0.697
Apgar score (5th min) 8.79 ± 0.72 8.71 ± 0.75 8.75 ± 0.73 b0.697
Gender (F/M) 21/13 19/15 40/28 c0.768
Cesarean delivery n % 30 (88.2 %) 25 (73.5 %) 55 (80.8 %) d0.461
Mother’s age 30.6 ± 3.8 29.8 ± 3.3 29.6 ± 4.1 d0.082
Gravity n %
 1 18 (53 %) 19 (55.9 %) 37 (54.4 %) d0.072
 2 6 (17.6 %) 7 (20.6 %) 13 (19.1 %)
 3 10 (29.4 %) 8 (23.5 %) 18 (26.5 %)
Irisin (ng/ml)
 Median ± SD 39 ± 13 25 ± 8 32 ± 13 b0.001*
 Min–max 21–74 14–52 25–63
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recent study, Joung et al. found plasma irisin levels were 
positively correlated with gestational age (r  =  0.21, 
p < 0.001), and birth weight Z-score (r = 0.18, p < 0.001) 
(Joung et al. 2015). In that study, there was a significant 
difference between the gestational age of newborns (26–
41 GW), whereas in our study, the mean gestational week 
was found as GW  =  38.8  ±  0.4. Though it is stated in 
the same publication that, no significant correlation was 
found between the gestational week and irisin level in 
multivariate analysis (β = 0.005, p = 0.43), this result may 
be attributed to that, 257 cases were AGA and 60 were 
SGA newborns, because there is a numerically significant 
difference between the groups. In order to eliminate this 
difference, we equated the number of subjects in both 
groups (AGA = 34, SGA = 34). Again in the same report, 
no statistically significant difference was found between 
GW and irisin in contrary to the hypothesis of body 
mass index and BAT are correlated with irisine, which is 
emphasized in the same study (SGA, AGA, LGA median 
55.38, 64.41, 68.70 ng/ml; respectively). Because BMI and 
BAT of premature infants are low, independently from 
term newborns being SGA, AGA or LGA. In our study, 
in order to eliminate this difference all newborns enrolled 
were chosen from term infants (median 38.8 ± 0.4 GW). 
Furthermore, it is reported in the mentioned study that, 
singleton infants of mothers with preeclampsia had lower 
cord blood irisin levels compared to infants of mothers 
with our preeclampsia. Unlike that study, pregnants with 
the conditions that could affect irisin level such as mater-
nal preaclampsia, gestational diabetes, asthma, chronic 
disease or a history of drug use were excluded from our 
study.
In addition our study, mothers with gestational diabe-
tes, hypertension, asthma, chronic disease, use of drug or 
a history of smoking exposure were not included, because 
Garces et al. recently reported that circulating irisin lev-
els in pregnant women with preeclampsia were lower 
compared to women with healthy pregnancies in the 
third trimester (Garces et  al. 2014). Additionally, recent 
reports of irisin in relation to gestational diabetes mel-
litus (GDM) have shown controversial results between 
maternal circulating irisin levels and GDM (Yuksel et al. 
2014; Ebert et al. 2014).
Studies in the literature conducted with healthy adults 
found higher irisin levels unlike our study (Park et  al., 
n = 107 ng/ml) (Park et al. 2013). Whereas in the present 
study we found significantly lower irisin levels in infants 
compared to those in adults [median 30 (32 ± 13) ng/ml]. 
This difference might be attributable to the smaller mus-
cular mass in neonates. Because in human tissues, the 
distribution of FNDC5 expression was strongly increased 
in muscle in comparison with adipose tissue, simi-
lar to the findings described in mice (Huh et  al. 2012). 
Huh et  al. found, age-related muscle loss correlated to 
decreased circulating irisin concentration, muscle mass 
being the main predictor of this in humans. Furthermore 
Fig. 1 Cord irisin level in AGA and SGA group
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after bariatric surgery-induced weight loss, circulating 
irisin levels as well as muscle FNDC5 gene expression 
were significantly down-regulated (Huh et al. 2012).
I think that, likewise the study by Joung et  al., lower 
cord irisin levels found SGA infants in our study might 
be influenced by the smaller muscular mass as well as 
lower BAT (Joung et al. 2015). Because, José et al. found 
a positive association of FNDC5 gene expression with 
BAT markers (PRDM16 and UCP1), lipogenic (FASN 
and ACC), and the expression of insulin-pathway related 
genes (GLUT4 and IRS1), mitochondrial (MTCO3 and 
PGC1), and alternative macrophage markers (IL-10 and 
CD206) (José et  al. 2013). Also van Marken Lichtenbelt 
et  al. showed that the amount of BAT was significantly 
decreased in association with obesity, with a negative lin-
ear relationship between BAT, BMI, and percent body fat 
(van Marken Lichtenbelt et al. 2009).
Based on all these studies and the present study; I have 
thought that irisin which is recently rather emphasized 
for its association with insulin resistance and obesity and 
released by muscle tissue, regulating glucose homeostasis 
by influencing the BAT might be a physiopathological fac-
tor in explanation of the impaired carbohydrate metabo-
lism which is more common in SGA infants. Because 
both muscular mass and BAT are low in SGA infants.
Conclusion
Low levels of irisin in term infants with SGA may be a 
factor in explanation of the impaired carbohydrate 
metabolism in these infants. However, further studies 
with larger series are warranted to confirm this.
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